Sign in
x
☰

Drill into a subset of respondents

Updated at 2023-07-14 18:47:45 UTC

Standard charts

Press values in standard charts like "Excellent" in q2 to show results for just those respondents throughout the entire project.

Protobi interface displaying two question panels side by side. Left panel (q1): 'Generally, how would you say things are these days in your life' with responses Very happy (49.6%), Pretty happy (42.7%), Not too happy (6.0%), Don't know/Refused (1.7%), N=637. Right panel (q2): 'How would you rate your own health in general these days?' showing Excellent at 100.0% with a yellow bar, while Good, Only fair, Poor, and Don't know/Refused all show 0.0%, N=637.

Other chart types

Most chart values are also clickable and you can drill into respondents by pressing on a state, a portion of a pie/donut chart, or a bar on a column or bar chart. 

Protobi Choropleth map visualization titled 'In what state is your primary practice located?' showing a gradient-shaded US map with legend ranging from 2.8% to 8.2%. States are colored in varying shades of blue, with darker shades indicating higher percentages. California is labeled with a tooltip showing '7.0%'. Protobi Donut chart titled 'Sample overview' displaying the question 'What is your speciality (select only one answer)'. The donut chart shows two segments: General Practitioner occupying 60% in blue, and Practice Nurse occupying 40% in olive green. Legend appears in the top right. Protobi bar chart titled 'Bar by S1' showing 'What are your initial thoughts about the device you have just reviewed?' Responses are grouped by General Practitioner (orange) and Practice Nurse (green). Eight response categories are shown: #EASY TO USE (38.3%/47.5%), #GOOD (28.3%/5.0%), #DOSE INDICATOR (10.0%/7.5%), #ECO-FRIENDLY (10.0%/20.0%), #NOT EASY (6.7%/27.5%), #SIMILAR (6.7%/10.0%), #OTHER (5.0%), and #COST EFFECTIVE (3.3%/7.5%). A blue tooltip highlights the 43.9% value for Practice Nurse #EASY TO USE. Protobi discrete group chart titled 'On a scale from 1 to 5, how would you rate the following Hanahaki Disease therapies on their ability to reduce general HD disease risk?' Shows 8 therapies (bolciclovir, fotiazole, Diaclet®, estrantomib, andriaxone, cegriperone, gliacalcet, hifiramid) with horizontal stacked bars representing 6 response categories: Not efficient at all (dark blue), Slightly efficient (light blue), Somewhat efficient (gray), Very efficient (light green), Extremely efficient (green), and Don't know (gray). A blue tooltip shows 'Value: Extremely efficient, Percent: 35.4%, Freq: 191' for the fotiazole bar. Sample sizes range from n=100 to n=690.